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Abstract 1 
 2 
Streptococcus equi is the causative agent of strangles, a prevalent and highly 3 
contagious disease of horses. Despite the animal suffering and economic burden 4 
associated with strangles little is known about the molecular basis of S. equi 5 
virulence. Here we have investigated the contribution of a specific lipoprotein and the 6 
general lipoprotein processing pathway to the ability of S. equi to colonise equine 7 
epithelial tissues in vitro and to cause disease in both a mouse model and the natural 8 
host in vivo. Colonisation of air-interface organ cultures was significantly reduced 9 
after inoculation with a mutant strain deficient in the maturase lipoprotein (∆prtM138-10 
213) compared to infection with wild-type S. equi strain 4047 or a mutant that was 11 
unable to lipidate preprolipoproteins (∆lgt190-685). Moreover mucus production was 12 
significantly greater in both wild-type-infected and ∆lgt190-685-infected organ cultures. 13 
Both mutants were significantly attenuated in a mouse model of strangles compared 14 
with the wild-type strain, although 2/30 mice infected with the ∆lgt190-685 mutant did 15 
still exhibit signs of disease. In contrast only the ∆prtM138-213 mutant was significantly 16 
attenuated in a pony infection study with 0/5 infected ponies exhibiting pathological 17 
signs of strangles compared with 4/4 infected with the wild-type and 3/5 infected with 18 
the ∆lgt190-685 mutant. We believe that this is the first study to evaluate the 19 
contribution of lipoproteins to the virulence of a Gram positive pathogen in its natural 20 
host. These data suggest that the PrtM lipoprotein is a potential vaccine candidate 21 
and further investigation of its activity and its substrate(s) are warranted.  22 
Introduction 1 
The Group C streptococcus, Streptococcus equi (S. equi) is the aetiological 2 
agent of strangles, one of the most prevalent and important diseases of the horse 3 
(52). Nearly 30% of all reported equine infections worldwide may be attributable to 4 
this organism (8). Strangles is so-called because of the pharyngeal constriction which 5 
occurs as a consequence of lymph node swelling (often accompanied by 6 
abscessation) in the upper respiratory tract of the horse following the spread of 7 
infection from the nasopharynx. In approximately 5% of cases systemic spread of the 8 
organism leads to abscess formation in other organs resulting in the usually fatal 9 
condition known as ‘bastard strangles’ (44). There is comparatively little information 10 
regarding the molecular basis of virulence in S. equi (22). As in other pathogenic 11 
streptococci (4, 14, 32, 38) much work has focussed on the identification of secreted 12 
and surface-located components that may interact with the host (2, 16, 22, 27, 35). In 13 
this respect, a major development in the study of this important veterinary pathogen 14 
has been the availability of data from the S. equi genome project (http:// 15 
www.sanger.ac.uk/Projects/S_equi/).  16 
 One major mechanism by which Gram-positive bacteria can retain exported 17 
proteins within their cell envelopes is through lipid modification, which anchors these 18 
lipoproteins to the outer face of the plasma membrane (6, 48). Bioinformatic analysis 19 
of Gram-positive bacterial genomes, including those of Streptococcus pneumoniae, 20 
Streptococcus pyogenes and Streptococcus agalactiae, has revealed that 21 
lipoproteins are a numerically significant feature (ca. 2%) of their predicted 22 
proteomes (3, 46, 47, 50, 51). Moreover, the predicted functions of these putative 23 
lipoproteins include roles in nutrient acquisition, adherence, protein maturation and 24 
cell signalling. Thus lipoproteins are predicted to play important roles in the 25 
interactions between pathogenic bacteria and their hosts. Three S. equi lipoproteins 1 
have been characterised to date: LppC, a lipoprotein acid phosphatase enzyme (21); 2 
MBL, a putative metal-binding lipoprotein homologous to pneumococcal PsaA that is 3 
predicted to participate in ABC transporter-mediated uptake of manganese (23); and 4 
HAP, initially identified as hyaluronate (capsule) associated protein (10) but which is 5 
likely to act as a substrate-binding lipoprotein for ABC transporter-mediated uptake of 6 
oligopeptides (22). Bioinformatic analysis of the draft S. equi genome sequence has 7 
allowed us to identify at least 32 other putative lipoproteins (Sutcliffe and Harrington, 8 
unpublished observations) including a homologue (PrtM) of the pneumococcal 9 
vaccine candidate PpmA (33). Recently, the signal sequences of five of these 10 
putative lipoproteins were recovered in a screen for signal peptides using a phage 11 
display technique (27). 12 
 Bacterial lipoproteins are synthesised with distinctive Type II signal peptides 13 
that direct them into the Sec pathway for protein export (6, 17) and thence into a 14 
unique modification pathway which requires a minimum of two specific enzymes. 15 
Firstly, prolipoprotein diacylglyceryl transferase (Lgt) transfers a diacylglycerol moiety 16 
from membrane phospholipid substrates onto a critical cysteine residue in the 17 
cleavage region (‘lipobox’) of the type II signal peptide (36, 41). The lipid-modified 18 
prolipoprotein is then acted upon by a dedicated lipoprotein signal peptidase (Lsp) 19 
which cleaves the signal sequence preceding the thioether-modified cysteine, 20 
thereby leaving the lipid anchor unit at the N-terminus of the mature lipoprotein (41, 21 
54). These two steps are sufficient for lipoprotein anchoring and appear to be the 22 
extent of the pathway in many Gram-positive bacteria (46, 47).  23 
 This pathway for lipid modification of bacterial proteins is an attractive target 24 
for antimicrobial drug development as both the Lgt and Lsp enzymes are unique to 25 
prokaryotes. Likewise, as lipoproteins are likely to play important roles in host 1 
colonisation and bacterial virulence, individual lipoproteins have potential as targets 2 
for novel therapeutic or prophylactic (vaccine) strategies (28). Consistent with this are 3 
the findings that although Lgt is not apparently an essential enzyme during in vitro 4 
growth of Gram-positive bacteria (12, 29, 34, 39), an lgt mutant of S. pneumoniae 5 
was attenuated for virulence in a mouse model of infection (34) and the normal 6 
functions of Bacillus subtilis lipoproteins in protein secretion, sporulation and 7 
germination processes are impaired in lgt mutants (12, 25, 29, 39). Moreover, an Lgt 8 
mutant of Staphylococcus aureus that grew normally in rich media exhibited growth 9 
defects in minimal media, consistent with defects in lipoprotein-mediated nutrient 10 
uptake systems, notably ABC transporters (45). Similarly, although Lsp is 11 
dispensable for the growth of Gram-positive bacteria in vitro (18, 37, 40, 53, 55) 12 
studies using cell culture or animal models of infection show that Lsp is required for 13 
full virulence of Listeria monocytogenes (37), Mycobacterium tuberculosis (40) and S. 14 
aureus (11, 30). In contrast, inactivation of Lsp in Streptococcus suis did not appear 15 
to lead to an attenuation in virulence in a co-colonisation model of piglet infection 16 
(18). 17 
 We hypothesised that the lipid modification pathway is essential for full 18 
virulence of S. equi. As the Lgt enzyme catalyses the first and committed step on this 19 
path, we initially studied the contribution of this enzyme to the physiology and 20 
virulence of S. equi. In parallel we have investigated the deletion of a single, specific 21 
lipoprotein, namely the putative maturase lipoprotein (PrtM). We believe that this is 22 
the first study to evaluate the contribution of lipoproteins to the virulence of a Gram 23 
positive bacterial pathogen in its natural host. 24 
Materials and Methods 1 
 2 
 3 
Bacterial strains and culture conditions 4 
S. equi strain 4047 was originally isolated in 1990 from a submandibular 5 
abscess of a New Forest pony and has been maintained in the culture collection of 6 
the Animal Health Trust, Newmarket, UK. This strain is the subject of the S. equi 7 
genome sequencing project. Escherichia coli TG1 repA+, which allows the stable 8 
replication of the plasmid pG+host9 at 37oC, was kindly supplied by Dr Emmanuelle 9 
Maguin (Institut Nationale de la Recherche Agronomique, Jouy en Josas, France). S. 10 
equi was cultured at 37oC (unless otherwise stated). Liquid cultures were grown in 11 
Todd Hewitt broth (THB) plus 0.2% (w/v) yeast extract in an atmosphere containing 12 
5% CO2. Semi-solid cultures were grown on Todd Hewitt agar (THA) or Columbia 13 
base agar containing 5% defibrinated horse blood in an atmosphere containing 5% 14 
CO2. Mutant S. equi strains containing recombinant plasmids were grown on THA or 15 
in THB containing erythromycin at 0.5 or 1.0 µg ml-1 (THAE and THBE, respectively). 16 
E. coli strains were cultured in Luria-Bertani (LB) broth or agar at 37oC. 17 
 18 
Plasmids and primers 19 
The plasmids and primers used in this study are shown in Table 1. 20 
 21 
Construction of in-frame deleted lgt and prtM alleles  22 
In order to generate Lgt-deficient and PrtM-deficient mutants of S. equi 4047 23 
by allelic replacement, copies of the S. equi lgt and prtM genes containing in-frame 24 
deletions were constructed. For the Lgt mutant, PCR primers (SELGTAR 1U, 2L, 3U 25 
and 4L; Table 1) were designed based upon sequences found within the lgt gene and 26 
adjacent sequences. The 22 nucleotides at the 5’ end of primer SELGTAR 3U were 27 
designed to complement the SELGTAR 2L primer sequence. PCR using Pfu 1 
polymerase (Promega), S. equi 4047 chromosomal DNA and primers SELGTAR 1U 2 
and SELGTAR 2L generated the expected 526 bp DNA fragment.  A second PCR 3 
reaction with the SELGTAR 3U and SELGTAR 4L primers generated the expected 4 
496 bp DNA fragment. The PCR products from each reaction were diluted, mixed 5 
and allowed to anneal via their overlapping, complementary ends. A third PCR 6 
reaction was then carried out with these annealed DNA fragments as template and 7 
with primers SELGTAR 1U and SELGTAR 4L, again using the Pfu polymerase. The 8 
product of this reaction was a DNA fragment of 1022 bp containing the 5’ 189 base 9 
pairs and 3’ 96 base pairs (plus upstream and downstream sequences) but lacking 10 
the central 495 bp of the lgt gene.  The fragment was digested with the restriction 11 
endonucleases ApaI and SacII and cloned into the corresponding restriction sites of 12 
the pG+Host9 vector to give the recombinant plasmid pAH08. To generate a PrtM 13 
mutant, a copy of the prtM gene was constructed that lacked bases 411 to 639, 14 
which includes the sequence encoding most of the parvulin-like domain of the 15 
protein. Sequences flanking the deletion were generated by PCR using Vent DNA 16 
polymerase (New England Biolabs) with the primer pairs 5’PRTM/PRTM-NDEL and 17 
3’PRTM/PRTM-CDEL (Table 1). The corresponding 342bp and 376bp PCR products 18 
were then digested with the restriction endonucleases EcoRI and EcoRV (5’ product) 19 
and SalI and EcoRV (3’ product) and the digested products ligated into EcoRI and 20 
SalI digested pG+Host9:ISS1 plasmid in a three-way ligation to form the deletion 21 
construct, pGprtM∆. The engineering of an EcoRV site into primers as part of the 22 
cloning strategy results in the introduction of non-prtM DNA sequence encoding the 23 
amino acids aspartic acid and isoleucine at the site of the deletion. Plasmids pAH08 24 
and pGprtM∆ were transformed into E. coli TG1repA+ and transformants selected at 1 
37oC on LB plates containing erythromycin (150 µg ml-1).  2 
 3 
Allelic replacement mutagenesis. 4 
Transformation of the encapsulated S. equi strain 4047 with plasmids pAH08 5 
and pGprtM∆ was achieved using a modification of the method described by Simon 6 
and Ferretti (43). Briefly, an overnight culture of S. equi 4047 grown in THB 7 
containing hyaluronidase (30 µg ml-1) was diluted 20-fold in 200 ml of the same 8 
medium and grown to an OD595 of 0.125. Bacterial cells were harvested by 9 
centrifugation and washed three times in 10 ml volumes of ice-cold 0.5 M sucrose. 10 
After the final wash the pellet was resuspended in 1 ml of ice-cold 0.5 M sucrose and 11 
100 µl aliquots of the competent cells were used in transformation reactions. 12 
Transformations were performed with 1-5 µg plasmid DNA using a Gene Pulser 13 
electroporater (BioRad, UK) with pulse settings of 2.5 kV cm-1, 200Ω and 25 µF, 14 
typically giving a pulse time of 4-6 ms. Ice-cold THB was added to the transformed 15 
cells which were then incubated at 37oC for 3 h to allow cell recovery. Transformants 16 
were selected by plating serial dilutions of the cells on THAE followed by overnight 17 
incubation at 28oC (the permissive temperature) to allow plasmid replication. 18 
To replace the wild-type lgt and prtM genes with their respective in-frame 19 
deleted alleles, transformants containing either pAH08 or pGprtM∆ were subjected to 20 
two rounds of homologous recombination as previously described by Biswas et al. 21 
(5). The first recombination event, leading to the integration of pAH08 or pGprtM∆ 22 
into the strain 4047 chromosome, was achieved by growing transformants at 28oC 23 
overnight and then increasing the temperature to 37oC for 3 h. Integrants were 24 
selected following growth on THAE overnight at 37oC. Integrants were then 25 
inoculated into THBE and grown at 37oC overnight followed by dilution into THB and 1 
incubation at 28oC for a further 48 h. Incubation at the permissive temperature allows 2 
plasmid replication and facilitates the second recombination event. Bacteria were 3 
plated on THA and grown at 37oC to ensure excision of free plasmid. Putative mutant 4 
colonies were sub-cultured onto fresh THA and THAE plates to confirm their 5 
erythromycin sensitivity. The presence of the mutant allele in the chromosome of 6 
putative mutants was determined by PCR using the primers SELGTAR 1U and 7 
SELGTAR 4L for the lgt mutants and 5’PRTM and 3’PRTM primers for the prtM 8 
mutants. PCR products, representing the deletion derivatives of each allele, were 9 
generated using proof-reading DNA polymerases and the predicted deletions 10 
confirmed by DNA sequencing. DNA sequencing was performed by the University of 11 
Newcastle Central Facility for Molecular Biology using an ABI Prism 377 DNA 12 
sequencer or at the AHT using an ABI3100 DNA sequencer with BigDye fluorescent 13 
terminators. A representative mutant for each deleted allele was chosen for 14 
subsequent studies and designated ∆lgt190-685 and ∆prtM138-213 respectively. 15 
 16 
Analysis of the presence and localisation of lipoproteins 1 
Lack of Lgt activity in the ∆lgt190-685 mutant was confirmed by radiolabelling 2 
lipoproteins. Radiolabelling of S. equi lipoproteins was performed as previously 3 
described by Sutcliffe et al. (49).  4 
In order to demonstrate the presence of surface located lipoproteins in S. equi 5 
4047 and S. equi ∆lgt190-685 strains, TEM was performed as described by Dixon et al. 6 
(13). Western blotting was used to indicate the presence of lipoproteins in either cell 7 
extract or secreted protein profiles. The preparation of bacterial cell extracts, SDS-8 
PAGE and Western blotting were all performed as previously described (21). SDS-9 
solubilised cell extracts contain a mixture of both soluble and membrane-asscoiated 10 
proteins. The primary anti-LppC antibody used in this study was kindly provided by 11 
Dr Horst Malke and used at the recommended dilution. Cell-associated and 12 
supernatant acid phosphatase activities of wild type and mutant strains were 13 
determined spectrophotometrically as previously described (21).  14 
 15 
Investigation of virulence of S. equi mutants in an in vitro colonisation model 16 
Air interface respiratory organ cultures were constructed using equine upper 17 
respiratory tract tissues (nasal turbinate, guttural pouch and trachea) using methods 18 
described for human (26) and canine (1) tissue with some modifications. Tissues 19 
were obtained from an abattoir and washed in Dulbecco’s modified Eagle’s medium 20 
(DMEM) containing antibiotics (penicillin, 100 U ml-1; streptomycin, 50 µg ml-1; 21 
gentamicin, 100 µg ml-1; amphotericin, 2.5 µg ml-1) for 4 h to remove commensal 22 
flora. Following further washing in DMEM to remove residual antibiotics and 23 
amphotericin tissues were dissected into pieces approx 5 mm2 and mounted at an air 24 
interface on agarose platforms surrounded by 2.5 ml DMEM, in 6 well cell culture 25 
plates. Organ cultures were maintained in a humidified 5% CO2 incubator. Viability of 1 
air interface organ cultures was assessed using polystyrene bead clearance (1). 2 
Contamination was monitored by running a bacteriology loop around all 4 edges of 3 
the culture pieces and streaking onto horse blood agar plates. Any tissue pieces in 4 
which contamination was detected were discarded. Organ culture pieces were 5 
infected with a 10 µl suspension containing 1 x 105 colony forming units (cfu) of wild 6 
type S. equi 4047, ∆lgt190-685 or ∆prtM138-213 or were mock-infected with THB. 7 
Colonisation of organ culture pieces was assessed by measuring viable counts (6 8 
organ culture pieces per time point) of adherent bacteria at 4 h and 24 h post 9 
infection (p.i.). Organ culture pieces were vortexed for 15 s in PBS to remove non-10 
adherent bacteria and then homogenised before plating serial 10-fold dilutions onto 11 
THA and enumerating colonies. Changes in the surface features of organ culture 12 
pieces (2 per time point) in response to infection with wild type S. equi or the two 13 
mutants at 24 h p.i. were assessed by morphometric analysis of scanning electron 14 
microscopy (SEM) images of the epithelial surface. Tissues were processed and 15 
surface morphometry were carried out using standard methods (26). The percentage 16 
of the epithelial surface covered with mucus was recorded. Data represent the 17 
means and standard deviations of 6 independent experiments using tissues from 18 
different horses. Differences in colonisation and surface morphometry data were 19 
tested for statistical significance using Mann-Whitney U tests and are reported at the 20 
5% level. 21 
 22 
Investigation of the virulence of S. equi mutants
 
in a mouse model of strangles 1 
Mice were challenged intranasally as described by Chanter et al. (9). Briefly, 2 
thirty 3 to 4 week old female Balb/C mice were challenged with 4x106 cfu of fresh 3 
cultures of wild-type 4047, ∆prtM138-213 or ∆lgt190-685 S. equi strains and clinical signs 4 
of disease including weight loss and sneezing were compared with a group of 10 5 
unchallenged controls over a period of five days.  At the end of this period, mice were 6 
euthanased and examined for signs of S. equi infection (measured as viable S. equi 7 
counts) and pathology by histological examination of lymph nodes and tissues of the 8 
head and neck. The extent of pathology in each mouse was then graded, on the 9 
basis of pathological features most pertinent to S. equi infection, using the following 10 
scoring system: lymphadenitis [1], lymph node abscess [5], rhinitis [1], marked rhinitis 11 
[5], pharyngitis [3], meningitis [5], otitis media [3], lung lesions [5] and splenic lesions 12 
[5].  13 
 14 
Investigation of the virulence of S. equi mutants
 
in a pony challenge study 15 
Groups of 5 naïve, male yearling Welsh mountain ponies were challenged with 16 
either ∆prtM138-213 or ∆lgt190-685 and a similar control group of 4 male ponies with S. 17 
equi 4047. Each group was housed separately throughout the challenge period with 18 
strict infection control measures in place to ensure no cross-contamination between 19 
the groups. Fresh cultures of each strain were grown in THB supplemented with 10% 20 
foetal calf serum (THB10) at 37oC with 5% CO2 to an OD600nm of 0.3. Previous 21 
studies have shown that this density of bacteria corresponds to approx. 2 x 108 cfu 22 
ml-1 of S. equi 4047 (unpublished observations).  At this point cultures were diluted 23 
1:8 in fresh pre-warmed and pre-gassed THB10 and 2 ml of challenge inocula were 24 
administered via both nostrils using a flexible tube and spray nozzle, in order to 25 
administer approximately 1 x 108 cfu/pony. Clinical signs of disease including fever, 1 
swelling of the lymph nodes and nasal discharge were monitored daily for up to three 2 
weeks. Ponies were considered to be pyrexic when their temperature exceeded 3 
39.0oC. Clinical scores were calculated based on the scoring system presented in 4 
Table 2. Blood samples were collected to enable monitoring of the neutrophil levels 5 
present in challenged ponies.  Normally these range from 3 to 6.5 x 106 ml-1 in 6 
healthy ponies, but frequently exceed 1 x 107 ml-1 during S. equi infection. At the end 7 
of the study period, all of the ponies were euthanased and the extent of their disease 8 
quantified on post mortem examination using the following scoring system: abscess 9 
in a lymph node [15], micro-abscess in a lymph node [10], enlarged lymph node [1], 10 
empyaema of the guttural pouch [5], follicular hyperplasia of the guttural pouch [1]. 11 
Samples of lesions at post mortem were used to re-isolate the challenge organisms 12 
in order to confirm their identity by PCR of the lgt and prtM genes. 13 
 14 
Animal ethics 15 
These studies were performed under a Home Office project license after 16 
ethical review and following strict welfare guidelines. 17 
Results 1 
 2 
Identification of the lgt gene and construction of an Lgt-deficient allelic 3 
replacement mutant 4 
Our initial studies allowed the amplification of a 261 bp internal fragment of the 5 
S. equi 4047 lgt gene (Genbank accession number AJ403973), using degenerate 6 
primers based upon conserved amino acid sequences in the Lgt proteins of S. 7 
mutans, S. pneumoniae and S. pyogenes. The sequence was completed by 8 
subsequent PCR experiments and verified by reference to an early release of the S. 9 
equi 4047 genome project. Putative promoter and ribosome binding site sequences 10 
were identified upstream of the lgt gene, which is located downstream of the hprK 11 
gene as in several other Gram positive bacteria (7, 24). The lgt gene of S. equi 4047 12 
encodes a 259 amino acid protein with a molecular weight of approximately 29.8 13 
kDa. The derived protein sequence contains the Lgt Prosite motif G-R-X-[GA]-N-F-14 
[LIVMF]-N-X-E-X(2)-G (PS01311/PDOC01015) and matches the Pfam profile 15 
(PF01790) for Lgt. An overlap-deletion PCR strategy was used to create a mutant lgt 16 
allele with a 495 bp in-frame deletion which removed this Prosite motif and was thus 17 
predicted to produce a non-functional Lgt enzyme. Replacement of the wild-type 18 
allele with the in-frame deletion derivative in S. equi ∆lgt190-685 was confirmed by PCR 19 
and sequencing. 20 
 21 
Radiolabelling of lipoproteins in S. equi 4047 and S. equi ∆lgt190-685 22 
To confirm the absence of Lgt activity in the allelic replacement mutant, S. 23 
equi 4047 and S. equi ∆lgt190-685 were grown in the presence of [14C] palmitate. 24 
Palmitate is incorporated into endogenous membrane lipids which are used as the 25 
substrate for lipid modification of preprolipoproteins by Lgt, thereby resulting in the 1 
radiolabelling of mature lipoproteins. Electrophoresis of cell extract proteins of the 2 
parent strain 4047 revealed the presence of at least 10 distinct, radiolabelled 3 
lipoproteins following autoradiography (Fig. 1, lane 1). In contrast there was an 4 
absence of labelled protein bands in equivalent cell extracts of the mutant strain (Fig. 5 
1, lane 2).  Intensive labelling at the bottom of each lane indicated comparable 6 
incorporation of the labelled palmitate into bacterial lipids (Fig. 1). This result 7 
confirmed the absence of functional Lgt activity in the mutant.  8 
 9 
Investigation of the effect of Lgt mutation on the processing of a known S. equi 10 
lipoprotein 11 
In order to determine the effect of Lgt mutation on the processing of an 12 
individual lipoprotein, the presence of the S. equi LppC acid phosphatase (21) was 13 
investigated in the wild-type and mutant strains by Western blot analysis. As 14 
expected a single cross-reacting band representing the mature form of LppC was 15 
seen in cell extracts of the parent 4047 strain probed with an antibody to the 16 
Streptococcus equisimilis acid phosphatase LppC (Fig 2A, lane 2). When a cell 17 
extract of S. equi 4047 which had been treated with globomycin was analysed, a 18 
second cross-reacting band representing the pro-LppC form of the protein was seen 19 
(Fig. 2A, lane 1). The appearance of this additional, higher molecular weight band is 20 
consistent with the inhibition of lipoprotein signal peptidase II by globomycin (21). A 21 
cross-reacting doublet was seen in cell extracts of S. equi ∆lgt190-685 (Fig 2A, lane 3) 22 
although the cross-reacting bands were considerably less intense for this strain, 23 
despite an equivalent total protein load compared to the wild-type. Moreover, neither 24 
of the bands corresponded in molecular weight with the pro-LppC form seen in the 25 
globomycin-treated culture suggesting that the prepro-LppC form of the protein, 1 
which is unlipidated but retains its signal peptide, migrates faster than the pro-LppC 2 
form. The lower amount of cell-associated LppC observed for S. equi ∆lgt190-685 could 3 
be explained by a reduced retention of prepro-LppC in the cell membrane as a 4 
consequence of the inability of the mutant strain to modify this protein with lipid. 5 
Consequently we investigated the release of unlipidated LppC by performing 6 
Western blots on concentrated culture supernatants obtained from the cultures from 7 
which the cell extracts had been derived. There was a minor but detectable cross-8 
reacting protein in the supernatant of S. equi 4047 but not in the supernatant of S. 9 
equi ∆lgt190-685 (data not shown). It was also noticeable that the band detected in the 10 
supernatant of S. equi 4047 was smaller than the mature form of the protein seen in 11 
cell extracts of the same strain suggesting that a proportion of the membrane-12 
anchored LppC is released by proteolytic processing in the parent strain. Whole-cell 13 
acid phosphatase assays were also performed on each strain. As previously 14 
observed for S. equi strain 9682 (21), a peak of acid phosphatase activity at a pH 15 
optimum of 5 was readily detectable for S. equi 4047 but this activity was significantly 16 
reduced in the mutant strain S. equi ∆lgt190-685 (Fig. 2B). However, acid phosphatase 17 
activity was undetectable in the culture supernatants of both strains (data not shown) 18 
suggesting that the protein detected in Western blots of S. equi 4047 culture 19 
supernatants is probably not active. Further confirmation of a reduced level of LppC 20 
in the cell envelope of the mutant compared to the wild-type came from LppC-specific 21 
immunogold labelling experiments. Single cocci of S. equi 4047 and ∆lgt190-685 (n=10 22 
for each) were labelled with 234 ± 20 and 54 ± 20 gold particles, respectively. 23 
Cumulatively, these data suggested that there was a significant defect in LppC 24 
localisation within the cell envelope of S. equi ∆lgt190-685 compared to the parent 1 
strain. 2 
 3 
Construction of a PrtM-deficient allelic replacement mutant 4 
The S. equi ∆lgt190-685 mutant had been shown to be defective in the 5 
processing of lipoproteins generally (Fig. 1). To gain further insight into the 6 
significance of specific lipoproteins in S. equi, we created a S. equi mutant strain 7 
defective in the function of the putative maturase lipoprotein, PrtM. The PrtM 8 
sequence was identified from the S. equi genome project and, in addition to its 9 
homology to pneumococcal PpmA (33), it also exhibits significant homologies to the 10 
maturase proteins of other Gram positive bacteria (15, 19, 56, 57). This family of 11 
sequences belong to the parvulin family of PpiC-type peptidyl-prolyl cis-trans 12 
isomerases (PPIase). A S. equi mutant (∆prtM138-213) was constructed with an in-13 
frame internal deletion in the prtM coding sequence corresponding to the central 14 
(parvulin-like) PPIase domain (57). This mutant is predicted to synthesise a non-15 
functional PrtM protein, although the absence of an in vitro assay for PrtM function 16 
precludes experimental confirmation of this. Growth of both the S. equi ∆lgt190-685 and 17 
the ∆prtM138-213 mutants in nutrient rich broth was comparable to that of the wild type 18 
S. equi (data not shown). 19 
 20 
Colonisation of air interface organ cultures by S. equi strains 21 
 22 
Following inoculation of nasal turbinate, guttural pouch and tracheal organ 23 
culture pieces with 1 x 105 cfu wild type S. equi 4047 or the two mutants, all three 24 
strains were recovered from all three tissues at 4 h p.i (Fig. 3A). At 24 h p.i. wild type 25 
S. equi and ∆lgt190-685 were again recovered whereas ∆prtM138-213 was not detected. 26 
Wild type bacteria were recovered in statistically significantly higher numbers at both 1 
4 h and 24 h p.i. from nasal turbinate (3.8 ± 0.35; 3.4 ± 0.55) and guttural pouch (4.0 2 
± 0.60; 4.2 ± 0.70) cultures than from tracheal cultures (2.8 ± 0.25; 1.3 ± 0.80). The 3 
numbers of ∆lgt190-685 recovered at 4 h and 24 h p.i. from turbinate (3.9 ± 0.50; 2.8 ± 4 
0.70), guttural pouch (3.2 ± 0.45; 3.62 ± 0.80) and tracheal (2.4 ± 0.45; 1.1 ± 0.60) 5 
cultures were not significantly different from those of wild type S. equi. However, 6 
there were significantly fewer ∆prtM138-213 recovered at 4 h and 24 h p.i. from nasal 7 
turbinate (1.8 ± 0.30; <0.7 ± 0), guttural pouch (1.4 ± 0.45; <0.7 ± 0) and tracheal (0.7 8 
± 0.50) cultures than both wild type S. equi and ∆lgt190-685.  9 
 10 
Changes in surface epithelial morphology of air interface organ cultures 11 
exposed to S. equi strains 12 
 13 
The surface morphology of uninfected organ culture pieces from nasal 14 
turbinate, guttural pouch and trachea was predominantly ciliated epithelium. The 15 
guttural pouch and tracheal cultures were densely and uniformly ciliated whereas 16 
nasal turbinate tissue exhibited a mixture of ciliated and non-ciliated epithelial cells. 17 
In all three tissues after 24 h in culture a small percentage of the total epithelial 18 
surface area was covered with mucus (Fig. 3B) and the amount of surface coverage 19 
in the uninfected control pieces was not significantly different to that at the start of the 20 
experiment. Wild-type S. equi induced a marked mucus response which resulted in a 21 
significantly greater proportion of the epithelial surface being covered by mucus in all 22 
three tissues (nasal turbinate 86 ± 18%; guttural pouch 95 ± 22%; trachea 90 ± 14%). 23 
The mucus formed a dense layer that obscured the underlying ciliated epithelium 24 
(Fig. 4B). Inoculation of ∆lgt190-685 also induced a mucus response at 24 h pi in all 25 
three tissues. The amount of mucus coverage of the epithelial surface was 26 
significantly greater (nasal turbinate 75 ± 12%; guttural pouch 86 ± 16%; trachea 82 ± 27 
20%) than the uninfected control pieces but was not significantly different from pieces 1 
infected with wild-type S. equi (Fig. 3B). Qualitatively the mucus layer produced 2 
appeared less dense than that produced in response to wild-type S. equi (Fig. 4C). In 3 
contrast to infection with both wild-type S. equi and ∆lgt190-685, inoculation of ∆prtM138-4 
213 did not result in a significant increase in mucus production compared to uninfected 5 
control pieces (Fig. 3B), with the result that the ciliated epithelial surface was not 6 
obscured by mucus (Fig. 4D).  7 
 8 
Virulence of S. equi mutants in a mouse model of strangles 9 
The virulence of the mutants was determined in a mouse intranasal infection 10 
model of strangles (9). As expected, approximately 60% of mice challenged with the 11 
parent 4047 strain lost or failed to gain weight over the 5-day study period, indicative 12 
of S. equi infection (Fig. 5A).  S. equi 4047 also induced sneezing from 3 days post 13 
challenge (Fig. 5B) and had induced significant levels of disease in mice as 14 
determined by post mortem examination 5 days post challenge (Fig. 5C & 5D). 15 
Deletion of either the lgt or prtM genes significantly attenuated S. equi on intranasal 16 
challenge of mice as measured by weight gain, sneezing rate, pathological score and 17 
the overall incidence of disease (Fig. 5A-D). Mice challenged with either ∆lgt190-685 or 18 
∆prtM138-213 generally continued to gain weight in line with mock-challenged controls. 19 
However, 2 of 30 mice challenged with the ∆lgt190-685 strain had reduced weight gain 20 
when compared with unchallenged controls. Two mice challenged with ∆lgt190-685, 21 
including one of the mice that had failed to gain weight, also had histological disease 22 
on post mortem examination (Fig. 5D).  23 
 24 
Virulence of S. equi mutants in a pony challenge study 25 
The parent strain and both mutants were assayed for virulence in Welsh 1 
mountain ponies. The early clinical signs of strangles disease such as pyrexia, nasal 2 
discharge and swelling of the submandibular lymph nodes were apparent from day 2 3 
post-challenge in 3/4 ponies challenged with the parental strain 4047 and from day 4 4 
in 3/5 ponies challenged with the ∆lgt190-685 deletion mutant (Fig. 6A-C).  In contrast, 5 
there were no signs of disease observed in ponies challenged with the ∆prtM138-213 6 
deletion strain throughout the 17-day study period (Fig. 6A-C). There was a rise in 7 
mean rectal temperature, from day 4 post-challenge in the ponies challenged with 8 
wild-type 4047 compared to those challenged with both ∆lgt190-685 and ∆prtM138-213 9 
(Fig. 6A). Moreover, pyrexia (a temperature exceeding 39.0oC) was evident in 3/4 of 10 
the 4047-challenged group compared with 1/5 of the ∆lgt190-685-challenged group and 11 
0/5 of the ∆prtM138-213 challenged group (Fisher’s exact p = 0.048; Fig. 6B). Other 12 
clinical signs were also significantly reduced in ∆prtM138-213-challenged ponies 13 
compared with the wild-type challenged group (Kruskal-Wallis test p = 0.0267; Fig. 14 
6C).  There was no significant difference in the mean clinical scores of the ∆lgt190-685-15 
challenged group compared to the 4047-challenged ponies (Figure 6C). Similarly, 16 
whereas neutrophilia (>6.5x106 ml-1) was observed by day 17 in both wild-type and 17 
∆lgt190-685-challenged groups, neutrophil levels in ∆prtM138-213-challenged ponies 18 
remained stable (Fig. 6D). 19 
On post mortem examination, lymph node abscesses were apparent in all 4 20 
ponies challenged with the parental 4047 strain, 3 of 5 ponies (p = 0.44) challenged 21 
with the ∆lgt190-685 strain and 0 of 5 ponies (p = 0.008) challenged with the ∆prtM138-22 
213 strain (Fig. 7A). The mean pathological scores determined at post mortem were 23 
very similar for the 4047 and ∆lgt190-685 groups, whereas the low score obtained for 24 
the ∆prtM138-213 group reflected low-grade pathology not indicative of strangles (Fig 25 
7B).  S. equi was isolated from the abscesses of ponies in the 4047 and ∆lgt190-685 1 
groups in high yields (in excess of 109 cfu/ml of pus) and these isolates were 2 
confirmed by PCR to have the full-length or truncated lgt gene, respectively, thus 3 
confirming the source of infection and in vivo stability of the lgt deletion.  No S. equi 4 
was re-isolated from any of the ∆prtM138-213 challenged ponies on post mortem 5 
examination, suggesting that this strain was not able to persist in vivo for the 3-week 6 
duration of this study. 7 
 8 
Discussion 9 
Comparatively little is known about the molecular basis of S. equi virulence 10 
(22). Greater understanding should identify rational candidates for the development 11 
of an effective vaccine. It is considered that prevention of strangles is likely to be the 12 
only effective mechanism for combating the disease as the lack of vascularity 13 
associated with abscessation prevents the delivery of effective doses of antibiotics 14 
and other drugs to the site of infection.  15 
 Bacterial lipoproteins are attractive as potential vaccine candidates since they 16 
may be exposed on the bacterial surface and thus potentially accessible by host 17 
immune molecules (28, 51). Furthermore a wide variety of functions have been 18 
attributed to bacterial lipoproteins, at least some of which are likely to be crucial to 19 
bacterial colonisation and survival within the host (46-48). Thus immune responses 20 
directed at such proteins may be highly opsonic and may also block the activity of 21 
essential proteins. In the present study we investigated the contribution of 22 
lipoproteins to S. equi physiology and virulence. To this end, we have characterised 23 
the consequences of disrupting both the lipoprotein biosynthetic pathway per se and 24 
of inactivating a specific lipoprotein, PrtM.  25 
In order to construct a lipoprotein-deficient mutant of S. equi 4047 the wild-1 
type lgt gene was replaced by a mutant allele that contained a 495 bp internal 2 
deletion that removed the central portion of Lgt, including the highly conserved 3 
sequence motif that defines the Lgt family of enzymes. An allelic replacement 4 
strategy was chosen so as to minimise the potential for polar effects due to the 5 
mutation. The successful construction of an Lgt-deficient mutant (S. equi ∆lgt190-685) 6 
was confirmed by PCR and by palmitate radiolabelling which clearly showed that the 7 
mutant strain lacked labelled lipoproteins (at least 10 of which could be seen in the 8 
parent strain). The ability to generate a viable, Lgt-deficient mutant indicates that the 9 
absence of Lgt in S. equi is not lethal, a finding also observed for other Gram positive 10 
organisms such as B. subtilis (12, 29, 39), S. pneumoniae (34) and S. aureus (45).  11 
The failure to transfer a lipid moiety to preprolipoproteins, due to Lgt 12 
inactivation, would be predicted to result in either the accumulation of signal peptide-13 
anchored preprolipoproteins in the cell membrane or the release of the lipoprotein 14 
derivatives into the culture medium, due to either shedding or signal peptide 15 
processing at ‘cryptic’ signal peptidase I processing sites (‘shaving’). In order to 16 
determine which of these possibilities did indeed occur for individual lipoproteins in 17 
the S. equi ∆lgt190-685 strain, the localisation of a proven lipoprotein was investigated 18 
by Western blot analysis. Whilst it was clear that there was reduction in the level of 19 
the LppC acid phosphatase in cell extracts of the S. equi ∆lgt190-685 mutant, there was 20 
no corresponding increase in the amount of this protein in culture supernatants. It 21 
appears, therefore, that the failure of this protein to become lipid modified may result 22 
in its degradation either before or during secretion, although it remains possible that 23 
expression of this protein is altered in the S. equi ∆lgt190-685 mutant.  24 
Despite the demonstration, by palmitate labelling, that the S. equi ∆lgt190-685  1 
mutant contained no detectable lipoproteins, a protein cross-reacting with the anti-2 
LppC antibody was present in cell extracts of the S. equi ∆lgt190-685  mutant albeit at 3 
significantly lower levels than in the parent strain. The cross-reacting band also 4 
appeared to have a very similar molecular weight compared to that of the wild type 5 
(mature) lipoprotein. The most likely explanation for this observation is that the LppC 6 
protein seen in S. equi ∆lgt190-685 is not lipidated but that the LppC preprolipoprotein is 7 
proteolytically modified, yielding a product of similar size to the mature acid 8 
phosphatase in the parent strain. Comparable ‘mature-like lipoproteins’ have been 9 
reported previously in B. subtilis, L. monocytogenes and S. suis mutants lacking the 10 
Lsp signal peptiase II (18, 37, 53). Most significantly, differential processing of 11 
lipoprotein precursors has been observed in an lsp mutant of M. tuberculosis: 12 
whereas the mutant accumulated both prolipoprotein and a ‘mature-like’ form of a 19 13 
kDa lipoprotein, only the prolipoprotein forms of a 27 kDa and the MPT83 lipoproteins 14 
accumulated (40).  15 
    Although the phenotype of the S. equi ∆lgt190-685 did not correspond with 16 
that originally predicted (i.e. preprolipoprotein accumulation), convincing 17 
autroradiographic, Western blot,  acid phosphatase enzyme assay and 18 
immunolocalisation data all confirmed a significant defect in lipoprotein processing in 19 
this strain.  20 
We intended to investigate the virulence of the S. equi ∆lgt190-685 mutant in a 21 
variety of in vitro and in vivo models of colonisation and disease and also decided to 22 
generate a mutant that was deficient in a single specific lipoprotein. For the purpose 23 
of this study we chose the putative maturase lipoprotein PrtM, one of four lipoproteins 24 
released in large amounts by an Lgt mutant of S.aureus (45). 25 
 1 
Air interface respiratory organ cultures of nasal turbinate, guttural pouch and 2 
tracheal tissues were used to compare the ability of wild-type S. equi, the ∆lgt190-685 3 
mutant and a PrtM-deficient mutant (∆prtM138-213), to colonise tissues derived from a 4 
variety of anatomical sites within the equine upper respiratory tract (URT) and to 5 
assess the response of URT tissues to infection. Previous studies have shown that 6 
culturing respiratory tract tissues at an air interface provides a more physiological 7 
infection environment for bacterial pathogens than submerged culture systems (31, 8 
59). Viable and contamination-free tissues from all three regions were successfully 9 
maintained for the duration of the experiment. Colonisation was assessed by 10 
measuring the numbers of bacteria adherent to tissues at 4 h and 24 h p.i. Wild-type 11 
S. equi was present in higher numbers on nasal turbinate and guttural pouch tissues 12 
than on tracheal tissues, suggesting less efficient colonisation of the trachea. The 13 
numbers of the ∆lgt190-685  mutant adherent to organ culture pieces were not 14 
significantly different from those of wild-type S. equi suggesting that this mutant was 15 
capable of colonising nasal turbinate, guttural pouch and tracheal tissues as 16 
efficiently as wild-type bacteria. In contrast, however, the ∆prtM138-213 mutant was 17 
present in significantly reduced numbers compared to wild-type S. equi in all three 18 
tissue sites at both time points measured. These data suggest that the ∆prtM138-213 19 
mutant has impaired ability to colonise the equine URT.  20 
The response of the equine URT to infection with wild-type S. equi and the two 21 
mutants was assessed by SEM morphometric analysis of the epithelial surface. 22 
Uninfected cultures from all three anatomical regions had a small surface area 23 
covered by mucus. Wild-type S. equi induced a marked mucus response that 24 
obscured the epithelial surface. It was not possible to assess the underlying 25 
epithelium by SEM analysis although light microscopy suggested that this was intact 1 
and, furthermore, organ culture pieces infected with the wild-type bacteria continued 2 
to clear beads despite the production of mucus (data not shown). This extensive 3 
mucus response has been noted for other bacterial pathogens using air interface 4 
organ cultures of human (59) and canine (1) origin. The mutant ∆lgt190-685 also 5 
induced a marked mucus response that was not different from wild-type S. equi. 6 
Although the amount of mucus produced in these experiments was not quantifiable, 7 
the depth of the mucus layer induced by ∆lgt190-685 appeared thinner than that 8 
produced by wild-type infection because the epithelial surface could be discerned 9 
beneath. In contrast, ∆prtM138-213 did not induce a mucus response, and organ culture 10 
pieces infected with this mutant were indistinguishable from the uninfected control 11 
pieces in this regard.  12 
Taken together, the organ culture colonisation and tissue response data 13 
suggest that colonisation of the URT (and/or possibly production of soluble factors by 14 
the bacteria) is required to induce a mucus response.  Both wild-type S. equi and 15 
∆lgt190-685 colonised the epithelium to a similar extent and induced a similar mucus 16 
response whereas ∆prtM138-213 was less able to colonise, was cleared from all tissue 17 
sites within 24 h p.i. and did not induce a mucus response. Since colonisation is the 18 
first step in pathogenesis these in vitro data suggest that ∆prtM138-213 is likely to have 19 
reduced virulence in the natural host. However, it should be noted that persistence 20 
and abscess formation in the horse would require evasion of the immune response, 21 
which was not assessed in the air interface organ culture models.  22 
In the mouse S. equi model (9), challenge with the parental S. equi 4047 strain 23 
induced disease in 57% (17/30) of mice during the 5-day study period as determined 24 
by changes in weight gain, rate of sneezing and histopathological analysis. The 25 
deletion of the prtM gene significantly attenuated S. equi in the mouse model of S. 1 
equi infection (p <0.001). None of the mice challenged with ∆prtM138-213 showed signs 2 
of disease (either reduced weight gain or sneezing) throughout the study period and 3 
no disease was detected histologically. The ∆lgt190-685 strain was also significantly 4 
attenuated in the mouse S. equi infection model (p <0.001).  However, 3 of 30 mice 5 
challenged with ∆lgt190-685 had histological signs of disease and/or reduced weight 6 
gain when compared with unchallenged controls, indicating that this strain is not 7 
completely avirulent in mice. 8 
Investigation of the in vivo virulence of the ∆lgt190-685 and ∆prtM138-213 deletion strains 9 
was determined in the natural host via intranasal challenge of Welsh Mountain 10 
ponies. Ponies challenged with the parental S. equi 4047 strain developed obvious 11 
signs of strangles during the 17-day study period as determined by pyrexia (3 of 4 12 
ponies), clinical observations (4 of 4 ponies) and post mortem examination (4 of 4 13 
ponies). The ∆prtM138-213 strain was significantly attenuated for each of these 14 
parameters and did not induce signs of pyrexia (0 of 5 ponies, P = 0.048), significant 15 
clinical signs of disease (0 of 5 ponies, P = 0.027) or obvious signs of disease on 16 
post mortem examination (0 of 5 ponies, P = 0.008) during the same 17-day study 17 
period. The presence of lymph node swelling in 1 of 5 ponies and follicular 18 
hyperplasia of the guttural pouch in all 5 ponies challenged with ∆prtM138-213 may be 19 
indicative of an immune response directed against this strain and suggests that, 20 
although not detected at 17-days post challenge, the ∆prtM138-213 strain may persist 21 
for a short time in vivo. The ∆lgt190-685 strain generated early clinical signs of strangles 22 
in 3 of 5 ponies challenged. S. equi isolated from the lesions in these ponies all 23 
contained the deleted version of the lgt gene indicating that the strain had not 24 
reverted in vivo and thus that the presence of functional Lgt is not an absolute 25 
requirement for virulence in the natural host. However, there were no signs of 1 
strangles in 2 of the 5 ponies challenged with ∆lgt190-685 and there was an overall 2 
reduction in the degree of pyrexia in this cohort. This suggests that whilst this 3 
deletion mutant is not statistically significantly attenuated in the pony, there was a 4 
trend towards reduced incidence of disease compared with the parental 4047 strain, 5 
consistent with our findings in the other models. The stronger attenuation of the 6 
∆lgt190-685 strain in the mouse model compared with ponies may reflect differences in 7 
either the nature of bacterial-host interactions between the two species or differences 8 
in host responses to infection. It is notable, for example, that the wild type strain 9 
causes disease in 100% of infected ponies but only 60% of infected mice. Our data 10 
demonstrate that, ultimately, it is important to evaluate virulence attenuation in the 11 
natural host.   12 
 13 
The increased attenuation observed upon deletion of the prtM gene compared 14 
with deletion of the lgt gene suggests that lack of lipidation of PrtM does not 15 
completely eliminate its functional activity. In this context it is important to note that 16 
whilst deletion of lgt is not, in itself, lethal in B. subtilis (12, 29, 39) the PrsA 17 
lipoprotein is essential: the reduction of the cellular levels of PrsA below a critical 18 
threshold of ca. 200 molecules per cell results in cellular lysis (56). Thus it is likely 19 
that some residual functional activity may be retained by preprolipoproteins in Lgt 20 
mutants, perhaps during transient membrane association prior to shedding, shaving 21 
or proteolytic degradation. Similar conclusions have been drawn previously based on 22 
the absence of a significant growth defect in an Lgt mutant of S. aureus (45) and an 23 
Lsp mutant of Lactococcus lactis (55). In B. subtilis the in vivo function of PrsA 24 
apparently derives from the interaction of the central parvulin-like domain with the 25 
flanking N- and C-terminal domains (57). However, a PrsA deletion mutant (PrsAN+C), 1 
which is comparable to the ∆prtM138-213 mutant described herein, was unable to 2 
restore growth of PrsA-depleted cells although it did exhibit weak activity in an AmyQ 3 
secretion assay (57). Our studies suggest that deletion of the central domain of S. 4 
equi PrtM is sufficient to abrogate its function in vivo, thereby attenuating this strain. 5 
Some maturases, such as the plasmid-encoded PrtM of L. lactis, have clearly defined 6 
substrates (19, 20) whereas the role of the chromosomally encoded PpmA maturase 7 
has not yet been defined (15). Similarly, PrsA of B. subtilis may have a more 8 
pleiotropic role in protein secretion (57) and the Bacillus anthracis genome encodes 9 
three functional PrsA homologues that may have distinct but overlapping substrate 10 
specificities (58). Further analyses of the molecular consequences of the deletion of 11 
prtM in S. equi are now required in order to identify those virulence factors reliant on 12 
its activity and which are essential to pathogenicity in the horse. 13 
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 1 
Table 1. Oligonucleotide primers and plasmids used in this study 1 
 2 
Primer/plasmid Sequence or description Reference 
Primers* 
 
 
SELGTAR 1U  5’-GGGCCCGTCATCTCCTTGAGATTCGTG-3’  
SELGTAR 2L 5’-GATTCTTGCTCCAATAATTGCC-3’  
SELGTAR 3U 5’-GGCAATTATTGGAGCAAGAATCGTTTCTCAATACATGTCGGTG-3’  
SELGTAR 4L 5’-CCGCGGATAATTTAGAAGCGACCTTGC-3’  
5’PRTM  5’-GGGGAATTCAAGTGTCATTACGATGAAGG-3’  
PRTM-NDEL 5’-GGGGATATCGTAATCAGCATCTGTCAGCTC-3’  
3’PRTM 5’-GGGGTCGACTTTCTGACTTAGATTTAGAAG-3’  
PRTM-CDEL 5’-GGGGATATCGAGGGTGATATTTCAGAGGTG-3’  
 
  
Plasmids   
pG+host9:ISS1 Replication thermosensitive derivative of pWV01 containing cloned ISS1 
sequence 
Maguin et al., 
1996 
pAH08 pG+host9:ISS1† containing in-frame deleted lgt gene of S. equi This study 
pGprtM∆ pG+host9:ISS1† ISS1 containing in-frame deleted prtM gene of S. equi This study 
pGEM-T T-A cloning vector Promega 
 3 
 4 
*Underlined sequences represent engineered restriction sites for Apa I (GGGCCC), Sac II (CCGCGG), EcoR I 5 
(GAATTC), EcoR V (GATATC) and Sal I (GTCGAC). The italicised sequence in SELGTAR 3U is the reverse and 6 
complementary sequence to the primer SELGTAR 2L sequence and provides the overlapping sequence for the 7 
overlap-deletion PCR strategy. 8 
 9 
†ISS1 sequence is completely removed during cloning strategy 10 
 11 
 12 
Table 2: Scoring system used to quantify disease burden in ponies. 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
* scores of left and right sides were added.  30 
Observation Grade Score 
Normal 0 
Serous 1 
Nasal * 
Mucopurulent 2 
Normal 0 
Slight 1 
Moderate 2 
Submandibular lymph 
node swelling * 
Severe 3 
Not present 0 Cough 
Present 1 
Figure 1. Labelling of lipoproteins in S. equi 4047 and the ∆lgt190-685 mutant with 1 
[14C] palmitic acid.  2 
SDS extracts of cells grown in the presence of [14C] radiolabelled palmitic acid were 3 
separated by SDS-PAGE. The dried gel was exposed to X-ray film for 24 h before 4 
developing. Lane 1, S. equi 4047 extract; lane 2, S. equi ∆lgt190-685 extract. The 5 
positions of molecular weight standards (in kDa) are shown on the left.  6 
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Figure 2. Changes in the nature (panel a) and the activity (panel b) of an acid 1 
phosphatase (LppC) in the S. equi ∆lgt190-685 mutant.  2 
A. Proteins in SDS extracts prepared from cells of the parent (4047) and mutant 3 
strain (∆lgt190-685 ) were separated by SDS-PAGE and transferred to nitrocellulose. 4 
Immunoblotting was carried out using a polyclonal antibody raised to the LppC acid 5 
phosphatase of S. equisimilis. Lane 1, globomycin–treated S. equi 4047; lane 2, S. 6 
equi 4047; lane 3, S. equi ∆lgt190-685.  7 
B. Whole cell acid phosphatase activity was determined for strain 4047 (♦) and the 8 
∆lgt190-685 mutant () across a range of pH values, by spectrophotometric changes 9 
associated with the release of p-nitrophenol from the substrate p-nitrophenol 10 
phosphate.  Results are representative of three different experiments. 11 
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Figure 3. Colonisation and morphometric analysis of air interface organ 1 
cultures infected with S. equi strains 2 
A. Recovery of viable bacteria 4 h and 24 h post-infection after infection of nasal 3 
turbinate, guttural pouch and tracheal air interface organ cultures with 1x 105 cfu wild-4 
type S. equi or the mutants ∆lgt190-685  and ∆prtM138-213. Data bars shown the mean 5 
viable counts (± SD) from 6 independent experiments.  6 
B. Surface morphometric analysis of nasal turbinate, guttural pouch and tracheal air 7 
interface organ cultures 24 h after infection with 5 log10 cfu wild-type S. equi or the 8 
mutants ∆lgt190-685  and ∆prtM138-213. Data bars shown the mean % surface coverage 9 
by mucus (± SD) from 6 independent experiments.  10 
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Figure 4. Morphology of air interface organ cultures exposed to S. equi strains 1 
Representative SEM micrographs of uninfected nasal turbinate organ culture pieces 2 
or pieces infected with 1 x 105 cfu wild type S. equi or the two mutants after 24 h in 3 
culture: A. Uninfected control; B. Wild type S. equi 4047; C. ∆lgt190-685; D. ∆prtM138-213. 4 
All images shown at x 2000 magnification. Scale bars = 10 micrometers.  5 
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Figure 5. Challenge of mice with the ∆lgt190-685 and ∆prtM138-213 deletion strains.  1 
A. The mean % increase in weight per mouse was calculated for each of the 2 
challenge groups. Mice succumbing to infection with wild type S. equi (n=30) lost or 3 
failed to gain weight in comparison to uninfected controls (n=10).  Groups of 30 mice 4 
challenged with the ∆lgt190-685 (lgt) and ∆prtM138-213 (prtM) continued to gain weight 5 
during the course of the study. Error bars indicate the standard error from the mean. 6 
* indicates a statistical significance of P<0.05 compared with wild type infected 7 
ponies.  8 
B. The mean number of sneezes in 2 minutes for groups of five, co-housed mice was 9 
calculated for each of the challenge groups.  Mice infected with parental S. equi 4047 10 
had a significantly elevated sneezing rate when compared with uninfected and 11 
∆lgt190-685 and ∆prtM138-213 challenged groups. Error bars indicate the standard error 12 
from the mean. * indicates a statistical significance of P<0.05 compared with wild 13 
type infected ponies. 14 
C. The extent of disease on histological examination of mice was quantified 15 
according to the scoring system outlined in Materials and Methods. The mean total 16 
score per mouse was calculated. Error bars indicate the standard error from the 17 
mean. * indicates a statistical significance of P<0.05 compared with wild type infected 18 
ponies. 19 
D. The number of mice with histological signs of disease attributable to S. equi 20 
infection following post mortem examination was compared to the number without 21 
histological signs of disease by Fisher’s exact test, to determine if deletion of the lgt 22 
or prtM genes significantly attenuated S. equi in the mouse infection model. 23 
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Figure 6.  Effect of intranasal challenge of ponies on rectal temperature, clinical 1 
scores and neutrophil levels. 2 
A. Rectal temperatures of ponies were taken daily from the day before to day 17 3 
post-challenge and the mean temperature per pony for each challenge group is 4 
shown.  5 
B. The number of ponies suffering from pyrexia in each group was compared by 6 
Fisher’s exact test. Ponies were considered pyrexic when their temperature 7 
exceeded 39oC. Only ponies challenged with the ∆prtM138-213 strain had a significantly 8 
reduced incidence of pyrexia (p = 0.048). 9 
C. The mean clinical score for each challenge group was calculated according to the 10 
scoring system presented in Table 2. Comparison of the total clinical score per pony 11 
over the study period using the Kruskal-Wallis test indicated that only the ∆prtM138-213 12 
deletion strain (prtM)
 
was significantly attenuated P = 0.0267.  13 
D. The mean number of neutrophils per ml of blood was quantified for each pony. 14 
Ponies developed signs of neutrophilia (neutrophil count >6.5x106 ml-1) 6 days post 15 
challenge with the parental 4047 strain, whereas ponies challenged with the  16 
∆lgt190-685 strain (lgt) developed neutrophilia 17 days post challenge and no signs of 17 
neutrophilia were observed in ponies challenged with the ∆prtM138-213 strain (prtM; p 18 
<0.05). Error bars indicate the standard error from the mean. * indicates a statistical 19 
significance of P<0.05 compared with wild type infected ponies. 20 
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Figure 7. Effect of intranasal challenge of ponies on the disease identified on 1 
post mortem examination.  2 
A. The number of ponies in each group with significant pathological signs of strangles 3 
attributable to infection with S. equi on post mortem examination were compared 4 
using Fisher’s exact test. Although 2 of 5 ponies challenged with the ∆lgt190-685 strain 5 
had no significant signs of disease, this was not statistically significant (P = 0.44). 6 
However, ponies challenged with the ∆prtM138-213 strain did have significantly reduced 7 
disease on post mortem examination (P = 0.008).  8 
B. The mean pathology score per pony was calculated for each of the challenge 9 
groups on post mortem examination using the scoring system outlined in Materials 10 
and Methods. Error bars indicate the standard error from the mean. * indicates a 11 
statistical significance of P<0.05 compared with wild type infected ponies..  12 
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